Ho-Man Yeung
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ho-Man Yeung has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
Bhishak Kamat
Department of Radiology, Temple University Hospital, Philadelphia, PA, USA
3 shared publicationsAnson O’yOung
Department of Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19104 USA
2 shared publicationsAsher Maitin
Department of Medicine, Lewis Katz School of Medicine, Temple University
2 shared publicationsCarly Sokach
Department of Medicine, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania, USA
2 shared publicationsChristina Martin
Department of Neurology, Temple University Hospital, Philadelphia, PA, USA
2 shared publicationsErin Pomerantz
Department of Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania
2 shared publications
Latest Publications
- 15 June 2026
- Published by Taylor & Francis in Journal of Addictive Diseases
- p. 1-8
Comparative outcomes of opioid withdrawal management strategy in patients with injection-related bacteremia
Hospitalized patients with opioid use disorder present unique clinical challenges, including higher rates of patient-directed discharge (PDD), incomplete treatment courses, and frequent readmissions. To compare outcomes in hospitalized patient encounters involving OUD and bacteremia that were ordered medications for opioid use disorder versus high-dose opioid agonist therapy (HDOAT) alone. This single-center, retrospective study included 268 OUD patients, 383 encounters, and 303 cases of bacteremia admitted to Temple University Hospital from Jan 1, 2020 through Dec 31, 2022. Outcomes of interest included PDD, 7 and 30-day readmission, inpatient mortality, length of stay (LOS), one year mortality and antibiotic completion. Bacteremia is a serious illness and requires long term treatment, thus it is an optimal model for this work. Of 383 encounters, 234 involved MOUD, and 149 involved HDOAT alone. Among the HDOAT group, doses were up to 2,070 MMEs/day. MOUD included buprenorphine and methadone. HDOAT included non-MOUD full agonist such as oxycodone and/or hydromorphone. For case-level outcomes, MOUD was associated with higher antibiotic completion (35.0% vs 23.3%, OR 1.77, p < 0.05). For encounter-level outcomes, MOUD was associated with lower PDD rates (38.5% vs 69.8%, OR 0.27, p < 0.0001) and longer LOS (8d vs 3d), seven-days readmission and inpatient mortality rates were similar between groups. However, 30-day readmission rate was lower in the MOUD group (32.9% vs 43.0%, OR 0.65, p < 0.05). PDD, readmission and mortality were similar regardless of timing of MOUD initiation ( 72h) or severity of opioid dependence. Notably, 23% of HDOAT cases successfully completed antibiotics, often across multiple encounters. MOUD initiation was associated with lower PDD and higher antibiotic completion rates. Timing of MOUD initiation did not affect outcomes. HDOAT may serve as a second-line approach to support continuity of care in patients declining MOUD.
- 15 June 2026
- Published by Taylor & Francis in Journal of Addictive Diseases
- p. 1-8
Comparative outcomes of opioid withdrawal management strategy in patients with injection-related bacteremia
Hospitalized patients with opioid use disorder present unique clinical challenges, including higher rates of patient-directed discharge (PDD), incomplete treatment courses, and frequent readmissions. To compare outcomes in hospitalized patient encounters involving OUD and bacteremia that were ordered medications for opioid use disorder versus high-dose opioid agonist therapy (HDOAT) alone. This single-center, retrospective study included 268 OUD patients, 383 encounters, and 303 cases of bacteremia admitted to Temple University Hospital from Jan 1, 2020 through Dec 31, 2022. Outcomes of interest included PDD, 7 and 30-day readmission, inpatient mortality, length of stay (LOS), one year mortality and antibiotic completion. Bacteremia is a serious illness and requires long term treatment, thus it is an optimal model for this work. Of 383 encounters, 234 involved MOUD, and 149 involved HDOAT alone. Among the HDOAT group, doses were up to 2,070 MMEs/day. MOUD included buprenorphine and methadone. HDOAT included non-MOUD full agonist such as oxycodone and/or hydromorphone. For case-level outcomes, MOUD was associated with higher antibiotic completion (35.0% vs 23.3%, OR 1.77, p < 0.05). For encounter-level outcomes, MOUD was associated with lower PDD rates (38.5% vs 69.8%, OR 0.27, p < 0.0001) and longer LOS (8d vs 3d), seven-days readmission and inpatient mortality rates were similar between groups. However, 30-day readmission rate was lower in the MOUD group (32.9% vs 43.0%, OR 0.65, p < 0.05). PDD, readmission and mortality were similar regardless of timing of MOUD initiation ( 72h) or severity of opioid dependence. Notably, 23% of HDOAT cases successfully completed antibiotics, often across multiple encounters. MOUD initiation was associated with lower PDD and higher antibiotic completion rates. Timing of MOUD initiation did not affect outcomes. HDOAT may serve as a second-line approach to support continuity of care in patients declining MOUD.
- 23 March 2026
- Published by Taylor & Francis in Journal of Addictive Diseases
- p. 1-6
Quality of life in people who inject drugs correlate with discharge outcomes and medication therapy initiation
Patients who inject drugs disproportionately experience frequent patient-directed discharge and readmissions. Assessment of quality of life may provide insight into individual barriers limiting health and addiction treatment. The relationship between QoL and discharge outcomes is unclear, particularly in the context of PWID in the inpatient setting. This study aimed to characterize the relationship between QoL, discharge outcomes, and treatment decisions of PWID in the inpatient setting. This was a single-centered study conducted at an urban tertiary care center during a six-month period. Patients self-administered a modified Drug User QoL scale. Demographic information, disposition, and medication therapies were obtained retrospectively. Comparisons were made based on disposition and treatment. Of 58 eligible participants, 36 completed the DUQOL. The median age was 38 years; 48% were male, and 54% reported homelessness. DUQOL scores were lower for PDD patients than non-PDD patients. Patients who initiated medications of opioid use disorder inpatient had higher DUQOL scores compared to those who declined. Initiation of MOUD was associated with significantly lower odds of PDD; however, there was no significant difference in 30-day readmission. DUQOL domains that had a discordance between importance and satisfaction on the DUQOL included "Housing," "Health," "Sense of Future," "Feeling Good," and "Being Useful." Higher QoL was observed to have better clinical outcomes and MOUD acceptance. DUQOL scores, particularly domains where there is a high discordance between satisfaction and importance, may serve as an important tool in predicting clinical outcomes and guiding treatment decisions.
- 23 March 2026
- Published by Taylor & Francis in Journal of Addictive Diseases
- p. 1-6
Quality of life in people who inject drugs correlate with discharge outcomes and medication therapy initiation
Patients who inject drugs disproportionately experience frequent patient-directed discharge and readmissions. Assessment of quality of life may provide insight into individual barriers limiting health and addiction treatment. The relationship between QoL and discharge outcomes is unclear, particularly in the context of PWID in the inpatient setting. This study aimed to characterize the relationship between QoL, discharge outcomes, and treatment decisions of PWID in the inpatient setting. This was a single-centered study conducted at an urban tertiary care center during a six-month period. Patients self-administered a modified Drug User QoL scale. Demographic information, disposition, and medication therapies were obtained retrospectively. Comparisons were made based on disposition and treatment. Of 58 eligible participants, 36 completed the DUQOL. The median age was 38 years; 48% were male, and 54% reported homelessness. DUQOL scores were lower for PDD patients than non-PDD patients. Patients who initiated medications of opioid use disorder inpatient had higher DUQOL scores compared to those who declined. Initiation of MOUD was associated with significantly lower odds of PDD; however, there was no significant difference in 30-day readmission. DUQOL domains that had a discordance between importance and satisfaction on the DUQOL included "Housing," "Health," "Sense of Future," "Feeling Good," and "Being Useful." Higher QoL was observed to have better clinical outcomes and MOUD acceptance. DUQOL scores, particularly domains where there is a high discordance between satisfaction and importance, may serve as an important tool in predicting clinical outcomes and guiding treatment decisions.
- 9 January 2026
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 371 (4) , 395-397
Assessing the utility of routine blood cultures in uncomplicated cellulitis in intravenous drug users
- 9 January 2026
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 371 (4) , 395-397
Assessing the utility of routine blood cultures in uncomplicated cellulitis in intravenous drug users
- 16 September 2025
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 371 (1) , 100-101
The bamboo ceiling: An underrecognized barrier for Asians and Asian Americans in academic medicine
- 16 September 2025
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 371 (1) , 100-101
The bamboo ceiling: An underrecognized barrier for Asians and Asian Americans in academic medicine
- Open Access
- 12 September 2025
- Published by Greater Baltimore Medical Center in Journal of Community Hospital Internal Medicine Perspectives
- Vol. 15 (5) , 6-11
Practical Pre-rotation Resources Enhance Knowledge and Attitude Towards Discharge Planning for Medical Students
Interdisciplinary discharge planning is known to be a difficult subject for medical students to comprehend given its convoluted nature. There is no standardized curriculum for students and there is a large variety between every inpatient rotations. Internal Medicine in particular sees variety of patients with unique psychosocial challenges. We previously proposed tools that are simple and specifically designed for learners and students including pyramid of discharge needs and disposition flow chart. Our current work examines the efficacy of using these resources by fourth year medical students during their subinternship rotation. Between May and September 2023, 54 students completed the rotation. Pre and post rotation surveys were administered to examine overall attitudes and knowledge about discharge planning. Comments and feedback from students were also reviewed. Our result showed a fundamental lack of knowledge by students in the roles of other discipline such as social workers and case managers. Furthermore, general attitudes and focus on discharge planning as essential part of patient care significantly improved. There were no in-group differences between student cohorts after the rotation. Students reported complementary design of these tools to their rotations and general positive perspectives overall. This study found that these customized rotation tools are useful to students and complementary to their rotations. The study finding suggests alternatives to student education outside of workshops and in person simulation.
- 12 September 2025
- Published by Greater Baltimore Medical Center in Journal of Community Hospital Internal Medicine Perspectives
- Vol. 15 (5) , 6-11
Open AccessPractical Pre-rotation Resources Enhance Knowledge and Attitude Towards Discharge Planning for Medical Students
Interdisciplinary discharge planning is known to be a difficult subject for medical students to comprehend given its convoluted nature. There is no standardized curriculum for students and there is a large variety between every inpatient rotations. Internal Medicine in particular sees variety of patients with unique psychosocial challenges. We previously proposed tools that are simple and specifically designed for learners and students including pyramid of discharge needs and disposition flow chart. Our current work examines the efficacy of using these resources by fourth year medical students during their subinternship rotation. Between May and September 2023, 54 students completed the rotation. Pre and post rotation surveys were administered to examine overall attitudes and knowledge about discharge planning. Comments and feedback from students were also reviewed. Our result showed a fundamental lack of knowledge by students in the roles of other discipline such as social workers and case managers. Furthermore, general attitudes and focus on discharge planning as essential part of patient care significantly improved. There were no in-group differences between student cohorts after the rotation. Students reported complementary design of these tools to their rotations and general positive perspectives overall. This study found that these customized rotation tools are useful to students and complementary to their rotations. The study finding suggests alternatives to student education outside of workshops and in person simulation.
- 26 June 2025
- Published by Elsevier in The American Journal of Medicine
- Vol. 138 (11) , 1513-1518
Forging the 'Bamboo Ceiling': A Narrative Review on the Impact to the Advancement of Asians, Asian Americans and Pacific Islanders in Medicine
- 26 June 2025
- Published by Elsevier in The American Journal of Medicine
- Vol. 138 (11) , 1513-1518
Forging the 'Bamboo Ceiling': A Narrative Review on the Impact to the Advancement of Asians, Asian Americans and Pacific Islanders in Medicine
- 1 February 2025
- Published by American College of Physicians in Annals of Internal Medicine: Clinical Cases
- Vol. 4 (2)
Broncho-Atmospheric Fistula Associated With Xylazine Wound
- 1 February 2025
- Published by American College of Physicians in Annals of Internal Medicine: Clinical Cases
- Vol. 4 (2)
Broncho-Atmospheric Fistula Associated With Xylazine Wound
- Open Access
- 4 January 2025
- Published by Greater Baltimore Medical Center in Journal of Community Hospital Internal Medicine Perspectives
- Vol. 15 (1) , 2-7
Inpatient versus Outpatient MRI? Outcomes for Hospitalized patients with New Liver Masses
No guidelines exist to guide hospitalists on whether inpatient MRI should be pursued for incidental liver masses. Here, we compare outcomes between patients who receive an inpatient MRI and those who did not, following detection of suspicious liver masses during hospitalization. A retrospective study of hospitalized patients with new HCC from Jan 1st, 2020 through Dec 31st, 2021 was conducted. Patients for hospice or with known HCC were excluded. Out of 34 unique subjects, 22 received MRI inpatient (IP) and 12 did not (non-IP). Time to inpatient MRI averaged 2.2 days. Inpatient LOS between the two groups were similar (6 v 7 days). IP group had lower lost-to-follow-up rates (4% v 42%). Median time to cancer treatment was similar (31 v 34 days), however IP group had higher treatment rate (68% v 42%). Obtaining inpatient MRI may benefit select high-risk patients, with increased follow-up rate and treatment rate for HCC.
- 4 January 2025
- Published by Greater Baltimore Medical Center in Journal of Community Hospital Internal Medicine Perspectives
- Vol. 15 (1) , 2-7
Open AccessInpatient versus Outpatient MRI? Outcomes for Hospitalized patients with New Liver Masses
No guidelines exist to guide hospitalists on whether inpatient MRI should be pursued for incidental liver masses. Here, we compare outcomes between patients who receive an inpatient MRI and those who did not, following detection of suspicious liver masses during hospitalization. A retrospective study of hospitalized patients with new HCC from Jan 1st, 2020 through Dec 31st, 2021 was conducted. Patients for hospice or with known HCC were excluded. Out of 34 unique subjects, 22 received MRI inpatient (IP) and 12 did not (non-IP). Time to inpatient MRI averaged 2.2 days. Inpatient LOS between the two groups were similar (6 v 7 days). IP group had lower lost-to-follow-up rates (4% v 42%). Median time to cancer treatment was similar (31 v 34 days), however IP group had higher treatment rate (68% v 42%). Obtaining inpatient MRI may benefit select high-risk patients, with increased follow-up rate and treatment rate for HCC.
- Open Access
- 1 January 2025
- Published by Wiley in Case Reports in Critical Care
- Vol. 2025 (1) , 7448355
Recognition of Transfusion‐Related Acute Lung Injury in a Patient With End‐Stage Liver Disease and Sepsis
A man in his 40s with history of decompensated cirrhosis presented with acute leg pain. On presentation, he was febrile, tachycardic, and jaundiced. Laboratory findings included leukocytosis with bandemia, anemia, elevated creatinine, hyponatremia, lactic acidosis, hyperbilirubinemia, and elevated INR. His model for end‐stage liver disease‐sodium (MELD‐Na) score was 32. Diagnostic paracentesis did not suggest spontaneous bacterial peritonitis, but blood cultures revealed Escherichia coli. He received intravenous fluids, broad‐spectrum antibiotics, and packed RBC. He became acutely dyspneic, 1 h into the transfusion. Over the next 36 h, he developed worsening hypoxia with infiltrates on serial chest x‐rays despite adequate diuresis. He required intubation for respiratory failure and his hospital course was complicated by hepatic encephalopathy. Ultimately, he was discharged on hospital Day 18 and was retrospectively diagnosed with transfusion‐related acute lung injury (TRALI) Type II. This case focuses on management of TRALI in sepsis and highlights the elevated risk of transfusion‐associated reactions in liver failure patients and its mortality and morbidity.
- 1 January 2025
- Published by Wiley in Case Reports in Critical Care
- Vol. 2025 (1) , 7448355
Open AccessRecognition of Transfusion‐Related Acute Lung Injury in a Patient With End‐Stage Liver Disease and Sepsis
A man in his 40s with history of decompensated cirrhosis presented with acute leg pain. On presentation, he was febrile, tachycardic, and jaundiced. Laboratory findings included leukocytosis with bandemia, anemia, elevated creatinine, hyponatremia, lactic acidosis, hyperbilirubinemia, and elevated INR. His model for end‐stage liver disease‐sodium (MELD‐Na) score was 32. Diagnostic paracentesis did not suggest spontaneous bacterial peritonitis, but blood cultures revealed Escherichia coli. He received intravenous fluids, broad‐spectrum antibiotics, and packed RBC. He became acutely dyspneic, 1 h into the transfusion. Over the next 36 h, he developed worsening hypoxia with infiltrates on serial chest x‐rays despite adequate diuresis. He required intubation for respiratory failure and his hospital course was complicated by hepatic encephalopathy. Ultimately, he was discharged on hospital Day 18 and was retrospectively diagnosed with transfusion‐related acute lung injury (TRALI) Type II. This case focuses on management of TRALI in sepsis and highlights the elevated risk of transfusion‐associated reactions in liver failure patients and its mortality and morbidity.
- 2 September 2024
- Published by Taylor & Francis in Journal of Addictive Diseases
- Vol. 43 (4) , 386-393
High dose opioid agonist therapy for patients with opioid use disorder: a case series exploring this patient-centered approach
Management of opioid withdrawal in the inpatient setting can vary widely depending on the patient, the physician, and the institution. Although buprenorphine and methadone are first-line therapy for withdrawal management, some patients experience barriers to those medications. In this case series, we explore high dose opioid agonist therapy (HDOAT) as a novel and effective option to bridge to recovery in this particular setting. This retrospective case series includes- five patients with opioid use disorder (OUD) who were treated with HDOAT while hospitalized and reports on their outcomes. All five patients completed lifesaving medical therapy, engaged with community health workers for resources, and successfully transitioned to medications for opioid use disorder (MOUD). More importantly, none of the patients had patient directed discharges (PDDs). Furthermore, there were no inpatient drug uses or overdoses requiring naloxone administration, even with very high doses of oxycodone. None of the five patients were readmitted within thirty days. Although more rigorous research is needed, HDOAT may be a viable strategy for OUD when patients continued to decline buprenorphine or methadone on admission. This case series demonstrated the successful use of this strategy toward preventing PDDs, promoting treatment completion, and allowing substance recovery and rehabilitation, in patients who elected to defer MOUD on arrival.
- 2 September 2024
- Published by Taylor & Francis in Journal of Addictive Diseases
- Vol. 43 (4) , 386-393
High dose opioid agonist therapy for patients with opioid use disorder: a case series exploring this patient-centered approach
Management of opioid withdrawal in the inpatient setting can vary widely depending on the patient, the physician, and the institution. Although buprenorphine and methadone are first-line therapy for withdrawal management, some patients experience barriers to those medications. In this case series, we explore high dose opioid agonist therapy (HDOAT) as a novel and effective option to bridge to recovery in this particular setting. This retrospective case series includes- five patients with opioid use disorder (OUD) who were treated with HDOAT while hospitalized and reports on their outcomes. All five patients completed lifesaving medical therapy, engaged with community health workers for resources, and successfully transitioned to medications for opioid use disorder (MOUD). More importantly, none of the patients had patient directed discharges (PDDs). Furthermore, there were no inpatient drug uses or overdoses requiring naloxone administration, even with very high doses of oxycodone. None of the five patients were readmitted within thirty days. Although more rigorous research is needed, HDOAT may be a viable strategy for OUD when patients continued to decline buprenorphine or methadone on admission. This case series demonstrated the successful use of this strategy toward preventing PDDs, promoting treatment completion, and allowing substance recovery and rehabilitation, in patients who elected to defer MOUD on arrival.